The Manufacturers Life Insurance Company Takes $9.44 Million Position in Avantor, Inc. $AVTR

Key Points

• The Manufacturers Life Insurance Company acquired 953,968 Avantor shares worth approximately $9.44 million, representing about 0.14% of the company. Institutional investors and hedge funds collectively own 95.08% of Avantor.
• Analyst sentiment remains largely neutral: 15 analysts rate Avantor a Hold, compared with two Buys and one Sell, with an average price target of $12.00.
• Avantor exceeded quarterly expectations, reporting $0.21 in adjusted EPS versus the $0.19 consensus and revenue of $1.69 billion versus $1.61 billion expected. Shares opened at $14.60, near their 12-month high of $15.93.

The Manufacturers Life Insurance Company acquired a new position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 953,968 shares of the company's stock, valued at approximately $9,444,000. The Manufacturers Life Insurance Company owned approximately 0.14% of Avantor at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Royal Bank of Canada increased its position in Avantor by 104.3% in the 1st quarter. Royal Bank of Canada now owns 203,738 shares of the company's stock valued at $3,302,000 after buying an additional 104,022 shares in the last quarter. Empowered Funds LLC increased its holdings in shares of Avantor by 40.3% during the first quarter. Empowered Funds LLC now owns 17,659 shares of the company's stock valued at $286,000 after acquiring an additional 5,075 shares in the last quarter. Cetera Investment Advisers increased its holdings in shares of Avantor by 40.2% during the second quarter. Cetera Investment Advisers now owns 40,289 shares of the company's stock valued at $542,000 after acquiring an additional 11,543 shares in the last quarter. Quantbot Technologies LP acquired a new position in shares of Avantor during the second quarter worth approximately $232,000. Finally, Arrowstreet Capital Limited Partnership raised its position in shares of Avantor by 214.9% during the second quarter. Arrowstreet Capital Limited Partnership now owns 124,076 shares of the company's stock worth $1,670,000 after purchasing an additional 84,679 shares during the period. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

AVTR has been the subject of several research reports. TD Cowen reissued a "hold" rating on shares of Avantor in a research report on Wednesday, July 15th. Royal Bank Of Canada upped their price objective on shares of Avantor from $9.00 to $14.00 and gave the stock a "sector perform" rating in a report on Thursday, July 30th. Wall Street Zen raised shares of Avantor from a "hold" rating to a "buy" rating in a research note on Saturday, June 27th. Citigroup lifted their price objective on shares of Avantor from $9.00 to $11.00 and gave the company a "neutral" rating in a report on Wednesday, July 8th. Finally, UBS Group set a $8.00 target price on shares of Avantor in a research report on Wednesday, June 24th. Two equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, Avantor presently has an average rating of "Hold" and an average price target of $12.00.

Avantor Stock Down 0.1%

Shares of NYSE:AVTR opened at $14.60 on Friday. The business's 50 day moving average is $12.12 and its 200 day moving average is $9.77. Avantor, Inc. has a 12-month low of $7.26 and a 12-month high of $15.93. The stock has a market cap of $9.87 billion, a price-to-earnings ratio of -17.38, a PEG ratio of 11.00 and a beta of 0.89. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65.

Avantor (NYSE:AVTR - Get Free Report) last announced its earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share for the quarter, topping analysts' consensus estimates of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The firm had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.61 billion. During the same quarter in the previous year, the business earned $0.24 EPS. The company's revenue was up .5% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. On average, sell-side analysts forecast that Avantor, Inc. will post 0.81 earnings per share for the current fiscal year.

Avantor Company Profile

Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor's offerings are organized across two primary segments.

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source